SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:umu-214985"
 

Search: onr:"swepub:oai:DiVA.org:umu-214985" > Improved survival i...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Improved survival in at-risk patients undergoing surveillance for hepatocellular carcinoma : a nationwide Swedish register-based study

Thörn, Richard (author)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
Hemmingsson, Oskar, 1975- (author)
Umeå universitet,Institutionen för kirurgisk och perioperativ vetenskap,Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
Danielsson Borssén, Åsa, 1977- (author)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
show more...
Werner, Mårten (author)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
Karling, Pontus (author)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
Wixner, Jonas (author)
Umeå universitet,Institutionen för folkhälsa och klinisk medicin
show less...
 (creator_code:org_t)
Dove Medical Press, 2023
2023
English.
In: Journal of Hepatocellular Carcinoma. - : Dove Medical Press. - 2253-5969. ; 10, s. 1573-1586
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Purpose: Surveillance for hepatocellular carcinoma (HCC) is recommended in at-risk patients, but its effectiveness in Western populations has been questioned. The purpose was to evaluate the effect of surveillance in patients with HCC in a Northern European setting.Patients and Methods: Data on patients diagnosed with HCC between 2009 and 2019 were collected from the nationwide Swedish National Registry for Tumors of the Liver and Bile Ducts (SweLiv). Patients who had undergone HCC surveillance were compared to those who had not (but had an obvious indication for surveillance, ie, liver cirrhosis or hepatic porphyria and an age of ≥50 years) regarding etiology, tumor burden, presence of extrahepatic spread, treatment and lead-time adjusted overall survival.Results: A total of 4979 patients with index HCC were identified and information regarding surveillance was available in 4116 patients. Among these, 1078 had got their HCC diagnosis during surveillance, whereas 1647 had been diagnosed without surveillance despite a presumed indication. The most common underlying etiologies for HCC were hepatitis C (28.2%) and alcoholic liver disease (26.9%), and 94.8% had cirrhosis. The surveillance cohort more frequently met the University of California San Francisco-criteria (79% vs 53%, p <0.001), more often received a potentially curative treatment (62% vs 28%, p <0.001) and had less extrahepatic spread (7.6% vs 22.4% p <0.001). After adjustment for lead-time bias (sojourn time of 270 days), the surveillance group had a significantly longer estimated median survival time than the non-surveillance group (34 months vs 11 months, p <0.001). A multivariable cox regression analysis showed an adjusted hazard ratio of 0.59 (95% CI 0.51–0.67) in favor of surveillance.Conclusion: Surveillance for HCC in at-risk patients is associated with diagnosis at an earlier tumor stage, treatment with curative intent and with improved lead-time adjusted overall survival. These findings encourage HCC surveillance of at-risk patients also in a Western population.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kirurgi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Surgery (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Gastroenterologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Gastroenterology and Hepatology (hsv//eng)

Keyword

chronic liver disease
cirrhosis
hepatocellular carcinoma
surveillance
survival

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view